Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01524276 · ClinicalTrials.gov registry record

Product Surveillance Registry

A clinical trial of Intracranial Aneurysm and Neurological Disorders, sponsored by Medtronic.

Recruiting
Registry status
100,000
Enrollment target
20
Study locations

NCT01524276 is a study of Intracranial Aneurysm and Neurological Disorders that is actively recruiting participants, run by Medtronic. The registered enrollment target is 100,000 participants, above the 2,053-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (4771% higher). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01524276, a study of Intracranial Aneurysm and Neurological Disorders, is actively recruiting participants, sponsored by Medtronic.

RECRUITING
Registry status
100,000 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Study Locations (20)

California

  • - Aliso Viejo
  • - Chula Vista
  • - Colton
  • - La Jolla
  • - Los Angeles
  • - Napa
  • - Redwood City
  • - Salinas
  • - San Diego
  • - Stanford
  • - Torrance
  • - Ventura

Colorado

  • - Aurora
  • - Colorado Springs
  • - Lakewood

Alabama

  • - Birmingham
  • - Huntsville

Arizona

  • - Chandler
  • - Phoenix

Arkansas

  • - Little Rock

Trial Details

FieldValue
Enrollment Target 100,000 participants
Start Date 2012-01
Est. Completion 2040-01

Sponsor

Medtronic

30 total trials

What the Registry Record Tells You About NCT01524276

The ClinicalTrials.gov registry entry for NCT01524276 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,053-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (4771% higher). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions.

NCT01524276 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Alabama.

Frequently Asked Questions

What is clinical trial NCT01524276 about?

NCT01524276 is a clinical study titled "Product Surveillance Registry". The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by stre...

What is the current status of trial NCT01524276?

This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2012-01. Estimated completion is 2040-01.

What conditions does trial NCT01524276 study?

This clinical trial studies the following conditions: Intracranial Aneurysm, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Mechanical Circulatory Support.

Who is sponsoring clinical trial NCT01524276?

This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01524276 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracranial Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.